Enaim Medical Center, Jerusalem, Israel.
J Cataract Refract Surg. 2012 Oct;38(10):1802-7. doi: 10.1016/j.jcrs.2012.05.033. Epub 2012 Aug 2.
To study the results of simultaneous photorefractive keratectomy (PRK) and corneal collagen crosslinking (CXL) in keratoconus after previous intrastromal corneal ring segment (ICRS) implantation.
Enaim Laser Center, Jerusalem, Israel.
Case series.
This study comprised patients with moderate keratoconus who had previous Intacs ICRS implantation with the Intralase laser at least 6 months before PRK-CXL. Wavefront-guided PRK and ultraviolet-A CXL were performed simultaneously. Refraction, uncorrected (UDVA) and corrected (CDVA) distance visual acuities, keratometry (K) values, endothelial cell count (ECC), pachymetry, corneal resistance factor (CRF), and corneal hysteresis (CH) were assessed 3, 6, and 12 months postoperatively.
Twelve months after PRK-CXL, the mean decimal UDVA improved significantly from 0.20 ± 0.12 (SD) to 0.55 ± 0.15 (P<.01). The mean decimal CDVA improved from 0.58 ± 0.13 to 0.77 ± 0.17 (P=.01). The mean cylinder decreased from -3.60 ± 1.70 to -1.30 ± 1.10 diopters (D) (P<.001). The mean apex K decreased from 50.91 ± 5.50 D to 46.61 ± 4.52 D (P<.005). The other corneal parameters did not change significantly after treatment. No significant difference was found between the 6-month and 12-month results. No patient lost lines of CDVA. Mild haze remained in 11.1% of eyes 12 months after treatment.
Simultaneous wavefront-guided PRK and CXL for keratoconus after ICRS implantation was safe and effective. It significantly improved the UDVA, CDVA, and central K value, and consequently the visual function, of patients with moderate keratoconus.
研究先前行基质内角膜环段(ICRS)植入术后行角膜交联(CXL)联合准分子激光角膜切削术(PRK)治疗圆锥角膜的效果。
以色列耶路撒冷 Enaim Laser 中心。
病例系列。
本研究纳入了先前使用 Intralase 激光行 Intacs ICRS 植入术且至少 6 个月后行 PRK-CXL 的中度圆锥角膜患者。行波前引导 PRK 和紫外线-A 交联术(CXL)联合治疗。术后 3、6、12 个月时评估屈光度、未矫正(UDVA)和矫正(CDVA)远视力、角膜曲率(K)值、内皮细胞计数(ECC)、角膜厚度、角膜阻力因子(CRF)和角膜滞后量(CH)。
PRK-CXL 术后 12 个月时,平均十进制 UDVA 从 0.20±0.12 显著提高至 0.55±0.15(P<.01),平均十进制 CDVA 从 0.58±0.13 提高至 0.77±0.17(P=.01),平均柱镜从-3.60±1.70 降低至-1.30±1.10 屈光度(D)(P<.001),平均角膜顶点 K 值从 50.91±5.50 D 降低至 46.61±4.52 D(P<.005)。治疗后其他角膜参数无明显变化。6 个月和 12 个月的结果无显著差异。无患者丧失 CDVA 视力。治疗后 12 个月,11.1%的患者遗留轻度混浊。
对于 ICRS 植入术后的圆锥角膜患者,行波前引导 PRK 和 CXL 联合治疗是安全有效的,可显著改善中度圆锥角膜患者的 UDVA、CDVA 和中央 K 值,从而改善其视力。